
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1064 | 1040 | 1140 | 1323 | 1647 | 2643 |
Fund Return | 6.42% | 3.95% | 14.04% | 9.77% | 10.49% | 10.21% |
Place in category | 218 | 323 | 461 | 424 | 353 | 106 |
% in Category | 16 | 19 | 32 | 35 | 39 | 14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Mellon Long Term Global Equity FuWG | 11.05M | 1.55 | 8.98 | 11.49 | ||
Mellon Long Term Global Equity FuWI | 3.71M | 1.55 | 8.98 | 11.49 | ||
Mellon Global Equity Income Fund SB | 1.16M | 6.33 | 9.20 | 9.66 | ||
Mellon Global Equity Income Fund SW | 6.18M | 6.43 | 10.01 | 10.48 | ||
Mellon Global Equity Income Fund St | 24.44M | 6.45 | 10.02 | 10.48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Guinness Global Equity Income Z | 6.63B | 3.98 | 11.53 | 11.54 | ||
Income Fund Sterling Accumulation | 4.09M | 6.79 | 8.96 | 9.81 | ||
Income Fund B Accumulation | 15.58M | 6.90 | 9.68 | 10.52 | ||
Income Fund B Income | 52.68M | 6.90 | 9.68 | 10.52 | ||
Income Fund Exempt 2 Income | 12.83M | 6.93 | 9.85 | 10.71 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
CME Group | US12572Q1058 | 3.31 | 262.54 | +0.11% | |
Cisco | US17275R1023 | 3.26 | 61.82 | +0.03% | |
Sanofi | FR0000120578 | 3.21 | 100.40 | -1.59% | |
Medtronic | IE00BTN1Y115 | 2.58 | 88.86 | +0.42% | |
AstraZeneca | GB0009895292 | 2.32 | 11,228.0 | -1.21% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review